Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nope it fantastic, huge great news. We are the first 25mg producer. That is huge. Sounds as though peeps on here wanted to get in lower but missed the boat, I really fell for you...lol NOT....
Boy is the shit flying on this board. 25mg and water, that's huge. And the arrivals about CBD being toxic is sheer BS.
The low volume may mean peeps are holding too, ever think of that? Think positive brother, its a lot better on your nerves. I imagine your invested in GNBT? If so here's some news that just came out. They are aquiering 8 more stores, maybe EverX will be on all the shelves in all of them, maybe this is why the 25mg drink is getting pushers to market. Look for the positive, makes life go a lot smoother imo.
MIRAMAR, FL -- March 29, 2019 -- InvestorsHub NewsWire -- Generex Biotechnology Corporation (www.generex.com) (USOTC: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is proud to announce that the company has successfully renegotiated a mutually agreed upon purchase price for certain assets of Veneto Holdings. As previously reported, on October 3, 2018, Generex affiliate NuGenerex Distribution Solutions 2, LLC (“NuGenerex”) agreed to purchase Veneto Group’s eight pharmacies, a wholesale pharmacy purchasing company, and an in-network laboratory. In consideration, NuGenerex executed and delivered to Veneto a promissory note in the principal amount of US $15 Million (the “First Tranche Note”). On November 1, 2018, NuGenerex completed the acquisition of the balance of the Veneto Group operating assets, consisting primarily of its management services organization (MSO) business and two additional ancillary service companies. In consideration of the sale, transfer, and assignment of those assets, NuGenerex executed and delivered to Veneto a secured promissory note in the principal amount of US $35 Million due January 15, 2019. The note was guaranteed by Joseph Moscato, Chief Executive officer of Generex, and retired and replaced the First Tranche Note.
The acquisition of selected Veneto Group assets is now complete. With this transaction, Generex, with the support of the Veneto Board, has renegotiated the purchase price to $21 million in an all-stock transaction at $2.50 per share, which equates to 8.4 million shares of GNBT Common Stock that will be paid from the dividend share pool [*See Note] to satisfy the obligations of Generex. The renegotiation centered around Generex’ continued assessment of the business operations of the acquired assets, including the evaluation of profitability, compliance with regulatory requirements, and organizational performance.
Under the guidance of Terry Thompson, President of NuGenerex Distribution Solutions (NDS) and Chief Operating Officer of Generex, the company has reorganized the Veneto assets to focus on building the MSO business and completely revamping the pharmacy model to yield a better use of capital and to avoid continual regulatory and contractual scrutiny from the established regulators, wholesalers, PBM’s, and insurers. The revised strategy is designed to be fully compliant with no direct pharmacy ownership and replacement of brick and mortar pharmacies with a nationwide network of contracted pharmacies to fulfil the business needs of the company.
Agree, getting the product out there is a major step. But being we already seen the PR about the agreement that it was still in place. No reason for me to think any different, its an on going flurry of updates which imo are great to know. But just because they didn't mention anything about them good or bad leads me to think everything is still in place with them. Its ok to be cautious if you maybe. Me I follow off each PR the direction we are going, there was nothing said to lead me believe there were any changes except we are the first for a 25mg drink, That's huge within itself.
Smart Nimble Small Cannabis Company Partnerships Stand Up To The Canopy Growth And Aurora Behemoths
Source: InvestorsHub NewsWire
?
New York, NY -- February 14, 2019 -- InvestorsHub NewsWire -- via NextBigTicker.com -- Bigger is not always better and in the world of a rapidly changing cannabis sector, the nimbleness of small cannabis companies may be more sustainable in the long run, and even outpace their giant competitors in the near-term. Small cannabis companies that form alliances to offset the resource advantage of larger competitors are in even better position to outperform the industry behemoths.
The military goes to combat ‘task organized.” Given the enemy at hand, a fighting unit mixes a combination of infantry, mechanized infantry, airborne infantry and armor together in a task organization unit specially designed to outmaneuver and overwhelm a target enemy. U.S. Army Veteran Steven Rash, CEO of USMJ (aka North American Cannabis Holdings (USOTC: USMJ) no doubt is trained in the strategy and tactics of military task organization.
In addition to his position at USMJ, Rash is also the CEO of ACI Conglomerated which is the majority shareholder of USMJ and Puration, Inc. (USOTC: PURA), as well as cannabis sector newcomers by way of reverse merger, Priority Aviation, Inc. (USOTC: PJET) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV). PURA has licensed a U.S. Patented cannabis extraction process in conjunction with the EVERx CBD Sports Water it produces from Kali-Extracts, Inc. (USOTC: KALY). Now KALY has partnered with PURA and NOUV in a Joint Venture (JV) called U.S. Cannabis Health to develop cannabis pharmaceuticals. Steven Rash is the CEO of U.S. Cannabis Health. The JV has forged a partnership with Generex Biotechnology (OTCBB: GNBT) in further pursuit of cannabis pharmaceuticals development. KALY and PURA have also partnered with Alkame Holdings, Inc. (USOTC: ALKM), currently the co-packer for PURA’s cannabis infused beverages, to make a new CBD infused beverage with an unprecedented 25 mg’s of CBD.
While big, exchange listed cannabis companies talk about developing cannabis beverages, PURA just launched a second-generation CBD infused beverage and has over $1 million in sales. The beverage is for sale on USMJ’s ecommerce site, www.usmj.com. While big, exchange listed cannabis companies talk about developing cannabis pharmaceuticals, KALY forges a partnership with an existing pharmaceutical company.
These small cannabis companies working together in a coalition are producing results not just operationally, but share price wise as well. The prices are volatile. That means they go up and down in price with a wide range between the highs and the lows. The stocks all trade at high volumes. So, not only does the smart, nimble small business coalition approach provide an improved ability to adapt, sustain and even get to market faster than their behemoth competitors, the high-volume volatility provides shareholders the opportunity to enjoy immediate and attractive returns. Buy low, sell high, wash rinse repeat.
There are other small cannabis business coalitions to look at as well. Get out there and do your research. Take a close look at the one discussed here. You will find the volatility cycle across the board at the moment is presenting an attractive entry point. The volume in all them is healthy and in USMJ, PURA, and KALY in particular, the current PPS level is on the lower end of their respective volatility cycles.
When it comes to investing in the bourgeoning and ever evolving cannabis sector, think small for big returns.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Source: www.nextbigticker.com
There was no mention it wasn't. Why do you think it isn't? Its about the new drink they were talking about and I comming out, just an update and when it should be out. Nothing other than that changed according to the PR, why question moving forward?.
Agree, everything in the works, filings sitting with OTC slowpokes, that's going to be the kicker when they finally get off their asses and get it done, then its all up and up from there. Dividends comming, all will be current and put that together with all the great news phamacitical, sales EverX, oops sorry, lol it will come. So with all theses tickets all at once. Its going to get real good in a short time here. Remember, were dealing with multiple tickets here, not just one and things aren't going to happen over night, business takes time especially with everything being worked on at once. Well worth the wait for the outcome...
I hope you get it too, soon. I'm interested in the ALKM deal plus Texas CBD bill being passed this week comming involving hemp and CBD. Right now NOUV is based in Texas, Canada, NY and looking too where ever ALKM is with more acreage and Kaly exstration facilities in the pike. This is getting better and better by the minute.
. PURA has partnered with Nouveau, Inc. (USOTC: NOUV) and Kali-Extracts (USOTC: KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process. “I had my cowboy boots on the ground yesterday, walking the 100 acers of already irrigated land where NOUV will soon plant hemp now that hemp farming has been legalized in the United States under the 2018 Farm Act,” said Brian Shibley, CEO of PURA. “NOUV already has staff and operations in place with an extensive 25 greenhouse traditional nursery operation generating revenue and paving the way forward future cannabis cultivation.” KALY and NOUV have already entered into a partnership to grow and extract on the 100 acers and now PURA will get first dibs on the CBD extract. “In addition to our deal with NOUV and KALY, we are also talking with our EVERx co-packer, Alkame Holdings, about an additional hemp cultivation operation near Alkame’s bottling facilities to include another KALY extraction facility actually within Alkame’s plant.” Alkame Holdings, Inc. (USOTC: ALKM) is a longtime co-packer partner of PURA for PURA’s EVERx and Telluride Happy Water beverages.
. PURA has partnered with Nouveau, Inc. (USOTC: NOUV) and Kali-Extracts (USOTC: KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process. “I had my cowboy boots on the ground yesterday, walking the 100 acers of already irrigated land where NOUV will soon plant hemp now that hemp farming has been legalized in the United States under the 2018 Farm Act,” said Brian Shibley, CEO of PURA. “NOUV already has staff and operations in place with an extensive 25 greenhouse traditional nursery operation generating revenue and paving the way forward future cannabis cultivation.” KALY and NOUV have already entered into a partnership to grow and extract on the 100 acers and now PURA will get first dibs on the CBD extract. “In addition to our deal with NOUV and KALY, we are also talking with our EVERx co-packer, Alkame Holdings, about an additional hemp cultivation operation near Alkame’s bottling facilities to include another KALY extraction facility actually within Alkame’s plant.” Alkame Holdings, Inc. (USOTC: ALKM) is a longtime co-packer partner of PURA for PURA’s EVERx and Telluride Happy Water beverages.
Couldn't tell you. It doesn't say for them Only. It says it will be out on shelves in 30 days. I would think both public and GNBT, that would be the smart thing to do in my opinion.
KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
Source: InvestorsHub NewsWire
KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
Dallas, TX -- March 29, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion. KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (USOTC: PURA) (“PURA”) leading EVERx CBD Sports Water. Few CBD beverages today even have 5 mg of CBD and now KALY will supply a 25 mg formulation. Management thoroughly evaluated the 25 mg CBD formulation for infusion into a drink that is clear looking and tasting in a suspension with an effective retail shelf-life. KALY indicates its formulation will be on shelves infused into its first beverage within the next 30 days.
?
KALY earlier this week announced that the State of Texas plans to remove hemp as a controlled substance next week in conjunction with the United States 2018 Farm Act is just the type of market condition management is looking for to support the implantation of the previously announced cannabis extraction lab to be dedicated to the 100 acre hemp farm to be operated by partner Nouveau (USOTC: NOUV). KALY and NOUV plan to partner on the development of a proprietary hemp cultivar dedicated to the advancement of KALY’s pharmaceutical extract developments. The continuing liberalization of cannabis laws such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing.
Last week, KALY published a research report on the recent pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates using an extract derived from KALY’s patented cannabis extraction process. The report details the study method and the significance of the study. The report includes specific findings and due to the substantial findings, the report includes guidelines for next stage tests.
The full report can be read on the company’s website at www.kali-extracts.com.
Goldman Small Cap Research Report has published an analyst research report on KALY that highlights KALY’s cannabis pharmaceutical value. The report is available under “research” on the OTCMarkets website. The research report is the first report from Goldman Small Cap Research as part of an ongoing research engagement. The report outlines the company’s current positioning and potential, upcoming milestones. The report is intended to augment the current information available on the OTCMarkets website. The report is also available to read or download, along with associated disclosures and disclaimers, at www.GoldmanResearch.com.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The first revenue generating contracts signed in December of 2018 will be reflected in the company’s upcoming annual report.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
Source: InvestorsHub NewsWire
KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
Dallas, TX -- March 29, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion. KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (USOTC: PURA) (“PURA”) leading EVERx CBD Sports Water. Few CBD beverages today even have 5 mg of CBD and now KALY will supply a 25 mg formulation. Management thoroughly evaluated the 25 mg CBD formulation for infusion into a drink that is clear looking and tasting in a suspension with an effective retail shelf-life. KALY indicates its formulation will be on shelves infused into its first beverage within the next 30 days.
?
KALY earlier this week announced that the State of Texas plans to remove hemp as a controlled substance next week in conjunction with the United States 2018 Farm Act is just the type of market condition management is looking for to support the implantation of the previously announced cannabis extraction lab to be dedicated to the 100 acre hemp farm to be operated by partner Nouveau (USOTC: NOUV). KALY and NOUV plan to partner on the development of a proprietary hemp cultivar dedicated to the advancement of KALY’s pharmaceutical extract developments. The continuing liberalization of cannabis laws such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing.
Last week, KALY published a research report on the recent pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates using an extract derived from KALY’s patented cannabis extraction process. The report details the study method and the significance of the study. The report includes specific findings and due to the substantial findings, the report includes guidelines for next stage tests.
The full report can be read on the company’s website at www.kali-extracts.com.
Goldman Small Cap Research Report has published an analyst research report on KALY that highlights KALY’s cannabis pharmaceutical value. The report is available under “research” on the OTCMarkets website. The research report is the first report from Goldman Small Cap Research as part of an ongoing research engagement. The report outlines the company’s current positioning and potential, upcoming milestones. The report is intended to augment the current information available on the OTCMarkets website. The report is also available to read or download, along with associated disclosures and disclaimers, at www.GoldmanResearch.com.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The first revenue generating contracts signed in December of 2018 will be reflected in the company’s upcoming annual report.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
Source: InvestorsHub NewsWire
KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
Dallas, TX -- March 29, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion. KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (USOTC: PURA) (“PURA”) leading EVERx CBD Sports Water. Few CBD beverages today even have 5 mg of CBD and now KALY will supply a 25 mg formulation. Management thoroughly evaluated the 25 mg CBD formulation for infusion into a drink that is clear looking and tasting in a suspension with an effective retail shelf-life. KALY indicates its formulation will be on shelves infused into its first beverage within the next 30 days.
?
KALY earlier this week announced that the State of Texas plans to remove hemp as a controlled substance next week in conjunction with the United States 2018 Farm Act is just the type of market condition management is looking for to support the implantation of the previously announced cannabis extraction lab to be dedicated to the 100 acre hemp farm to be operated by partner Nouveau (USOTC: NOUV). KALY and NOUV plan to partner on the development of a proprietary hemp cultivar dedicated to the advancement of KALY’s pharmaceutical extract developments. The continuing liberalization of cannabis laws such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing.
Last week, KALY published a research report on the recent pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates using an extract derived from KALY’s patented cannabis extraction process. The report details the study method and the significance of the study. The report includes specific findings and due to the substantial findings, the report includes guidelines for next stage tests.
The full report can be read on the company’s website at www.kali-extracts.com.
Goldman Small Cap Research Report has published an analyst research report on KALY that highlights KALY’s cannabis pharmaceutical value. The report is available under “research” on the OTCMarkets website. The research report is the first report from Goldman Small Cap Research as part of an ongoing research engagement. The report outlines the company’s current positioning and potential, upcoming milestones. The report is intended to augment the current information available on the OTCMarkets website. The report is also available to read or download, along with associated disclosures and disclaimers, at www.GoldmanResearch.com.
KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies. In addition developing pharmaceutical products internally and through partnerships, KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The first revenue generating contracts signed in December of 2018 will be reflected in the company’s upcoming annual report.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Right there with you on then trip 3s. And your right tommorow would be a great day for a killer update. Its comming, buys been picking up, think we get Texas legalized this week comming and OTC has the paper work on their desk. We just might get a double wammie comming at us. Hold tight...lol this is going to get real good around here.
Agree...
Like too see proof that theses are all scams. Bet you can't prove one is. Go away, take your unfounded speculation with you. Your not invested, what are you doing here? Protecting us? Lol yeah right....
According to a recent PR, its on the OTC desk. They are in slow motion. Be nice Texas and filing news hits at the same time...lol my goodness hold on for a huge ride.
Buys or sells, if they were buys, I'm surprise we didn't move up. Sells I really don't think it was an investor. M&Ms like playing their games here. My honest opinion, they are holding this down for the next run, which I thinks going to be a huge run, especially if they been pulling profit all this time, and Texas is supposedly going to push the hemp legalization throw by next week. I'm not budging from NOUV. This is the Silent Storm.....
Lol, kinda tough squeezing more funds out of my wife. I'm sitting good though, no worries, plus worst sineral, flip...lol
Makes you wonder...lol this can take off easy...
https://www.marketwatch.com/investing/stock/gchk
Is a night every time some gets in. Telling ya, get some peeps in here, create a little buying volume this takes great thrives in pps. Hope its starts picking up again in here. Gltya
Lol, watch, their going to paint it down eod, unless we hold our ground with a few ask smacked eod. MM games here, don't get discouraged hold tight, were going up soon.
WCVC Announces Continued EVERx CBD Sports Water Sales Growth
Source: InvestorsHub NewsWire
WCVC Announces Continued EVERx CBD Sports Water Sales Growth
Denver, CO -- March 28, 2019 -- InvestorsHub NewsWire -- West Coast Venture Group, Corp. (OTCBB: WCVC) (“WCVC”) today announced the company is enjoying continued growth of EVERx CBD Sports Water since introducing the beverage in its Illegal Burger restaurants last month. WCVC yesterday placed its third restock order this year. EVERx CBD Sports Water is produced by Puration, Inc. (USOTC: PURA).
?
WCVC announce earlier this week announced that the company is further solidifing its partnership with North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”). WCVC and USMJ entered into an agreement last year where WCVC agreed to manage the rollout in Denver of the AmeriCanna Cafe, founded by USMJ and spun-off into an independently listed public company. The independently listed company is Priority Aviation (USOTC: PJET) and a name change is pending in conjunction with the new cannabis restaurant business. Between the robust sales of EVERx and the response WCVC has had to their role in the AmeriCanna Cafe project, WCVC has decided to advance the relationship into an equity partnership so WCVC shareholders can benefit from the equity appreciation of the cannabis business WCVC is already managing. WCVC and USMJ expect to announce the details of their partnership in conjunction with the upcoming 420 celebration.
Learn more about USMJ at www.growusmj.com and www.usmj.com
Learn more about PURA at www.purationinc.comand www.drinkeverx.com
Learn more about WCVC at www.westcoastventuresgroupcorp.com and www.illegalburger.com
About West Coast Ventures Group Corp.
Based in Denver, Colo., West Coast Ventures Group Corp. (OTCBB: WCVC) develops, owns and operates two contemporary restaurant concepts: Illegal Burger, a quick-casual burger + bar concept, and El Señor Sol, a full-service fresh Mexican restaurant (6 total restaurant locations in the Denver, Colorado area). Led by seasoned restaurant entrepreneurs, WCVC management is committed to scaling both modern sustainable concepts into national franchise models operating metro-styled restaurants serving only the finest and freshest natural ingredients.
Forward-Looking Statements
This document may contain forward-looking statements, relating to West Coast Ventures Group Corp operations or to the environment in which it operates, which are based on West Coast Ventures Group Corp operations, estimates, forecasts and projections. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict, and/or are beyond West Coast Ventures Group Corp control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. Consequently, readers should not place any undue reliance on such forward-looking statements. West Coast Ventures Group Corp disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Jim Nixon
CEO West Coast Ventures Group, Corp.
+1(303)423-1300
info@illegalburger.com
https://www.westcoastventuresgroupcorp.com/ ;
https://www.illegalburger.com/
People said they recived their order. Don't know what's happening with your order, if you put in for one. But over all, PURA, Kaly and NOUV are moving forward. Hope you get your order soon, I'm sure you will, but until then, hang tight...lol have a great day..
It will all be reckoned with imo. Due time. They said no rs, there's other ways to deal with it. Love to see a buy back after the distribution of the dividend to PURA which I think will bring down the OS also. Am I asking for too much? Maybe, but I'm sure they will fix it once everything starts moving, meaning the litigation for legalizing hemp/CBD in Texas, planting this spring, Kaly moving in and sales. We shall see, like I said long haul, that's where I stand.
Lol, going the other way are we? Just a little reminder to let you know what's comming down the pike. Wouldn't wait to long. Texas to open up on hemp and CBD next week
Source: InvestorsHub NewsWire
PURA Announces Home-Grown Hemp For EVERx In Deal With KALY and NOUV
Dallas, TX – January 24, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) (“PURA”) today announced a home-grown source of hemp for its CBD extractions to go into its EVERx CBD Sports Water. PURA has partnered with Nouveau, Inc. (USOTC: NOUV) and Kali-Extracts (USOTC: KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process. “I had my cowboy boots on the ground yesterday, walking the 100 acers of already irrigated land where NOUV will soon plant hemp now that hemp farming has been legalized in the United States under the 2018 Farm Act,” said Brian Shibley, CEO of PURA. “NOUV already has staff and operations in place with an extensive 25 greenhouse traditional nursery operation generating revenue and paving the way forward future cannabis cultivation.” KALY and NOUV have already entered into a partnership to grow and extract on the 100 acers and now PURA will get first dibs on the CBD extract. “In addition to our deal with NOUV and KALY, we are also talking with our EVERx co-packer, Alkame Holdings, about an additional hemp cultivation operation near Alkame’s bottling facilities to include another KALY extraction facility actually within Alkame’s plant.” Alkame Holdings, Inc. (USOTC: ALKM) is a longtime co-packer partner of PURA for PURA’s EVERx and Telluride Happy Water beverages.
Yes the manipulation of the PPS, has been going on for awhile now. They are holding this down cause when we get financials, Texas opens up and updates this ticker, you will not be able to catch. Imo this is the silent storm out of all the tickers involve here. We are the producers for all products involved. No NOUV, no product. Plus were are located in NY, Canada and Texas and may still be looking at expanding. I'm here for the long haul. Imo this will be my most profitable ticker in pinky land. Glty.
Source: InvestorsHub NewsWire
PURA Announces Home-Grown Hemp For EVERx In Deal With KALY and NOUV
Dallas, TX – January 24, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) (“PURA”) today announced a home-grown source of hemp for its CBD extractions to go into its EVERx CBD Sports Water. PURA has partnered with Nouveau, Inc. (USOTC: NOUV) and Kali-Extracts (USOTC: KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process. “I had my cowboy boots on the ground yesterday, walking the 100 acers of already irrigated land where NOUV will soon plant hemp now that hemp farming has been legalized in the United States under the 2018 Farm Act,” said Brian Shibley, CEO of PURA. “NOUV already has staff and operations in place with an extensive 25 greenhouse traditional nursery operation generating revenue and paving the way forward future cannabis cultivation.” KALY and NOUV have already entered into a partnership to grow and extract on the 100 acers and now PURA will get first dibs on the CBD extract. “In addition to our deal with NOUV and KALY, we are also talking with our EVERx co-packer, Alkame Holdings, about an additional hemp cultivation operation near Alkame’s bottling facilities to include another KALY extraction facility actually within Alkame’s plant.” Alkame Holdings, Inc. (USOTC: ALKM) is a longtime co-packer partner of PURA for PURA’s EVERx and Telluride Happy Water beverages.
I really like this PR. Come on Texas.
Source: InvestorsHub NewsWire
PURA Announces Home-Grown Hemp For EVERx In Deal With KALY and NOUV
Dallas, TX – January 24, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) (“PURA”) today announced a home-grown source of hemp for its CBD extractions to go into its EVERx CBD Sports Water. PURA has partnered with Nouveau, Inc. (USOTC: NOUV) and Kali-Extracts (USOTC: KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process. “I had my cowboy boots on the ground yesterday, walking the 100 acers of already irrigated land where NOUV will soon plant hemp now that hemp farming has been legalized in the United States under the 2018 Farm Act,” said Brian Shibley, CEO of PURA. “NOUV already has staff and operations in place with an extensive 25 greenhouse traditional nursery operation generating revenue and paving the way forward future cannabis cultivation.” KALY and NOUV have already entered into a partnership to grow and extract on the 100 acers and now PURA will get first dibs on the CBD extract. “In addition to our deal with NOUV and KALY, we are also talking with our EVERx co-packer, Alkame Holdings, about an additional hemp cultivation operation near Alkame’s bottling facilities to include another KALY extraction facility actually within Alkame’s plant.” Alkame Holdings, Inc. (USOTC: ALKM) is a longtime co-packer partner of PURA for PURA’s EVERx and Telluride Happy Water beverages.
Can someone explain this statement? Thought PURA, Kaly and NOUV were partners already under USCH?
30%, 30%, 30%....
Quote off last Kaly PR;
"KALY and NOUV plan to partner on the development of a proprietary hemp cultivar dedicated to the advancement of KALY’s pharmaceutical extract developments. The continuing liberalization of cannabis laws such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing."
Is this something different, Not involving PURA, not that I care with PURA. I just don't get what their saying here when they are partners already.
All them selling tells me something is comming. You just don't see shit like that. I say we see a PR, today or by Friday. Something provoked the manipulation.
Manipulation, lol my goodness. Looks like their trying to make sure this doesn't go above 5. So freaking obvious. Their trying to even the buy/sell volume to keep her down. Freaking MM classic here files...
Here ya go.
PURA - Puration Begins To Outgrow Production Capacity And Plans Bottling Plant Expansion
Source: InvestorsHub NewsWire
?
PURA - Puration Begins To Outgrow Production Capacity And Plans Bottling Plant Expansion
Dallas, TX -- March 12, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) (“PURA”) today announced that the expanding demand for its EVERx CBD Sports Water is pushing the limits of its current bottling production capacity. “Having our orders for EVERx CBD Sports Water begin to overwhelm our bottling production capacity is an exciting problem,” said Brian Shibley, CEO of Puration. “While we are delighted to have great demand for EVERx, the risk of getting behind on production is nonetheless still a problem, no matter how exciting. We have some online customers already frustrated with slow delivery and that’s not good. We certainly don’t want to get behind with our wholesale buyers and we need to go above and beyond to make it up to our online buyers.” PURA recently announced beginning discussions with its current bottler about the possibility of PURA acquiring the bottler. The proposal to acquire the current bottler includes investment plans to expand the current bottler’s production capacity. “As we continue to innovate new beverages, a key bottling partner or in-house capacity its essential,” explained Mr. Shibley. PURA is also exploring independent bottling capacity acquisitions in addition to considering building out an all new plant. Management anticipates finalizing expansion plans by the end of this month. “Be it an acquisition or a new build out, the plan will be finalized this month and we will proceed quickly to expand production capacity one way or another.”
Analyst Speculative Buy Recommendation and $0.25 PPS Target with $0.35 Upside
Goldman Small Cap Research issued a research update on Puration, Inc. (USOTC: PURA) last week recommending a 'speculative-buy' rating with a target price-per-share of $0.25, with noted potential upside to the $0.35 mark.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
PURA board. I'm sure there's a ps stating it, but that's what everyone over there is posting
Humm, what's the date today? Looks like the EOM to meet. It says emo so be it, from news should be updated according to PR. Lets see if they stand by their work or if not tell us what the holdup is. Company makes annoucement as important as this, they better follow through with some word on it within its time frame stated.
More to look forward too, Texas, New York and Canada. Were getting bigger and bigger.
Kali-Extracts and Nouveau Announce Cannabis Extraction Partnership For Canadian Recreational Marijuana Market
Source: InvestorsHub NewsWire
Kali-Extracts and Nouveau Announce Cannabis Extraction Partnership For Canadian Recreational Marijuana Market
DALLAS, TX - December 21, 2018 -- InvestorsHub NewsWire -- Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans with Nouveau Life Pharmaceuticals (USOTC: NOUV) to use KALY’s patented cannabis extraction process in Canada. NOUV has a cannabis cultivation business with operations in the U.S. and Canada. The two companies will work together to produce cannabis extracts utilizing KALY’s patented cannabis extraction process for the recreational marijuana market.
KALY currently produces pharmaceutical grade cannabis extracts that have been involved in multiple clinical trials in addition to utilizing its patented cannabis extraction process in the production of CBD infused nutrition and wellness products to include its own Hemp4mula and CBD infused waters produced by Puration, Inc. (USOTC: PURA) (“PURA”).
KALY is partners with PURA and NOUV in a joint venture named US Cannabis Health for the purpose of together developing partnerships with pharmaceutical companies to develop cannabis pharmaceuticals. US Cannabis Health recently announced its first agreement with Generex Biotechnology, Corp. (OTCQB: GNBT).
To learn more about the KALY and NOUV project announced today, follow developments online at www.kali-extracts.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Kali, Inc.
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Tommorow supposally PURA buying out AKLM bottling company. This will be interesting to see if happens. Will it be under USCH or ACI?
Dallas, TX -- March 8, 2019 -- InvestorsHub NewsWire -- Alternet Systems, Inc. (USOTC: ALYI) (“ALYI”) today announced a license in the State of New York to grow hemp. The company has secured acreage in New York to grow and house the facility where hemp bast will be harvested for conducting further research within in the company’s hemp energy storage imitative. ALYI launched its hemp energy storage initiative late last year when the company brought Clarkson University Professor David Mitlin on board to lead a hemp energy storage initiative.
ALYI has engaged the services of Nouveau (USOTC: NOUV) (“NOUV”) to manage the hemp farming operations. Puration, Inc. (USOTC: PURA) (“PURA”) recently spun-off its cannabis cultivation operation to NOUV.
Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the State of Texas plans to remove hemp as a controlled substance next week conjunction with the United States 2018 Farm Act is just the type of market condition management is looking for to support the implantation of the previously announced cannabis extraction lab to be dedicated to the 100 acre hemp farm to be operated by partner Nouveau (USOTC: NOUV) in Texas. KALY and NOUV plan to partner on the development of a proprietary hemp cultivar dedicated to the advancement of KALY’s pharmaceutical extract developments. The continuing liberalization of cannabis laws such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing.